These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30028316)

  • 1. Molecular mechanism of noradrenaline during the stress-induced major depressive disorder.
    Seki K; Yoshida S; Jaiswal MK
    Neural Regen Res; 2018 Jul; 13(7):1159-1169. PubMed ID: 30028316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α
    Horrillo I; Ortega JE; Diez-Alarcia R; Urigüen L; Meana JJ
    Neuropharmacology; 2019 Nov; 158():107731. PubMed ID: 31376424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of selective serotonin and norepinephrine reuptake inhibitors on depressive- and impulsive-like behaviors and on monoamine transmission in experimental temporal lobe epilepsy.
    Kumar U; Medel-Matus JS; Redwine HM; Shin D; Hensler JG; Sankar R; Mazarati A
    Epilepsia; 2016 Mar; 57(3):506-15. PubMed ID: 26813337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects.
    Mahar I; Bambico FR; Mechawar N; Nobrega JN
    Neurosci Biobehav Rev; 2014 Jan; 38():173-92. PubMed ID: 24300695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?
    Pinder RM
    Neuropsychiatr Dis Treat; 2005 Mar; 1(1):3-7. PubMed ID: 18568121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated gene expression of glutamate receptors in noradrenergic neurons from the locus coeruleus in major depression.
    Chandley MJ; Szebeni A; Szebeni K; Crawford JD; Stockmeier CA; Turecki G; Kostrzewa RM; Ordway GA
    Int J Neuropsychopharmacol; 2014 Oct; 17(10):1569-78. PubMed ID: 24925192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system.
    Feinstein DL; Kalinin S; Braun D
    J Neurochem; 2016 Oct; 139 Suppl 2():154-178. PubMed ID: 26968403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurogenesis along the septo-temporal axis of the hippocampus: are depression and the action of antidepressants region-specific?
    Tanti A; Belzung C
    Neuroscience; 2013 Nov; 252():234-52. PubMed ID: 23973415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons.
    Szabo ST; Blier P
    Eur J Neurosci; 2001 Jun; 13(11):2077-87. PubMed ID: 11422448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies.
    Invernizzi RW; Garattini S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):819-27. PubMed ID: 15363606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatodendritic alpha2-adrenoceptors in the locus coeruleus are involved in the in vivo modulation of cortical noradrenaline release by the antidepressant desipramine.
    Mateo Y; Pineda J; Meana JJ
    J Neurochem; 1998 Aug; 71(2):790-8. PubMed ID: 9681471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locus coeruleus neuronal activity and noradrenaline availability in the frontal cortex of rats chronically treated with imipramine: effect of alpha 2-adrenoceptor blockade.
    Linnér L; Arborelius L; Nomikos GG; Bertilsson L; Svensson TH
    Biol Psychiatry; 1999 Sep; 46(6):766-74. PubMed ID: 10494444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
    Ogren SO; Kuteeva E; Hökfelt T; Kehr J
    CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal nitric oxide synthase and affective disorders.
    Zhou QG; Zhu XH; Nemes AD; Zhu DY
    IBRO Rep; 2018 Dec; 5():116-132. PubMed ID: 30591953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurogenesis and antidepressant action.
    Park SC
    Cell Tissue Res; 2019 Jul; 377(1):95-106. PubMed ID: 31165247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin 5-HT
    Perez-Palomar B; Mollinedo-Gajate I; Berrocoso E; Meana JJ; Ortega JE
    Neuropharmacology; 2018 May; 133():491-502. PubMed ID: 29477299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Getting the balance right: Established and emerging therapies for major depressive disorders.
    Perović B; Jovanović M; Miljković B; Vezmar S
    Neuropsychiatr Dis Treat; 2010 Sep; 6():343-64. PubMed ID: 20856599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.